SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-135690
Filing Date
2004-08-09
Accepted
2004-08-09 14:30:14
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 432092
2 AMENDED AND RESTATED 1995 STOCK PLAN dex101.htm EX-10.1 26384
3 CHANGE OF CONTROL AGREEMENT FOR CHRISTY SHAFFER dex102.htm EX-10.2 72571
4 FORM OF CHANGE OF CONTROL AGREEMENT dex103.htm EX-10.3 73372
5 CERTIFICATION dex311.htm EX-31.1 8781
6 CERTIFICATION dex312.htm EX-31.2 8783
7 CERTIFICATION dex321.htm EX-32.1 4463
8 CERTIFICATION dex322.htm EX-32.2 4465
  Complete submission text file 0001193125-04-135690.txt   633239
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 04960738
SIC: 2834 Pharmaceutical Preparations